SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-065485
Filing Date
2021-05-13
Accepted
2021-05-13 07:15:35
Documents
13
Period of Report
2021-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2115707d2_8k.htm   iXBRL 8-K 24908
2 EXHIBIT 99.1 tm2115707d2_ex99-1.htm EX-99.1 39712
  Complete submission text file 0001104659-21-065485.txt   250055

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lqda-20210513.xsd EX-101.SCH 3187
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lqda-20210513_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lqda-20210513_pre.xml EX-101.PRE 22711
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2115707d2_8k_htm.xml XML 3687
Mailing Address P.O. BOX 110085 RESEARCH TRIANGLE PARK NC 27709
Business Address P.O. BOX 110085 RESEARCH TRIANGLE PARK NC 27709 919.328.4400
Liquidia Corp (Filer) CIK: 0001819576 (see all company filings)

IRS No.: 851710962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39724 | Film No.: 21917172
SIC: 2834 Pharmaceutical Preparations